Inflammation as a Potential Therapeutic Target in IBS

M Cancian, G P D'Offizi, E Scala, R Paganelli, U Fagiolo, G C Sturniolo, Intestinal permeability in irritable bowel syndrome. Effect of diet and sodium cromoglycate administration. Annals of allergy. ,vol. 64, pp. 377- 380 ,(1990)

Vedat Goral, Mehmet Kucukoner, Huseyin Buyukbayram, None, Mast cells count and serum cytokine levels in patients with irritable bowel syndrome. Hepato-gastroenterology. ,vol. 57, pp. 751- 754 ,(2010)

Iris Posserud, Amanda Ersryd, Magnus Simrén, Functional findings in irritable bowel syndrome. World Journal of Gastroenterology. ,vol. 12, pp. 2830- 2838 ,(2006) , 10.3748/WJG.V12.I18.2830

K. Hanevik, V. Dizdar, N. Langeland, G. E. Eide, T. Hausken, Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 259- 260 ,(2011) , 10.1111/J.1365-2036.2011.04715.X

C. N. Andrews, T. A. Griffiths, J. Kaufman, N. Vergnolle, M. G. Surette, K. P. Rioux, Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndrome Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 374- 383 ,(2011) , 10.1111/J.1365-2036.2011.04732.X

Edward Lee, Lawrence R. Schiller, John S. Fordtran, Quantification of colonic lamina propria cells by means of a morphometric point-counting method Gastroenterology. ,vol. 94, pp. 409- 418 ,(1988) , 10.1016/0016-5085(88)90430-1

Pierre Desreumaux, Understanding the Mechanism of 5-ASA in Treating Colonic Inflammation Gastroenterología y Hepatología. ,vol. 4, pp. 319- 320 ,(2008)

Cristina Stasi, Maria Teresa Urbano, Dario Gambaccini, Santino Marchi, Massimo Bellini, Paolo Usai-Satta, Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World Journal of Gastroenterology. ,vol. 20, pp. 8807- 8820 ,(2014) , 10.3748/WJG.V20.I27.8807

L J Rather, Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. Bulletin of the New York Academy of Medicine. ,vol. 47, pp. 303- 322 ,(1971)

P. G. Farup, Questions about mesalazine and the irritable bowel syndrome Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 1036- 1037 ,(2011) , 10.1111/J.1365-2036.2011.04813.X